Table 3.

Flow Cytometry Analysis of the Effect of IL-10 Addition at Various Times Relative to SEB Incubation on SEB-Stimulated CD4+ T Cells

Treatment Cell Cycle Distribution (%)3-150
G1S G2/M
None >98  <1  <1  
IL-10 added 2 days before SEB  84.50 11.70  3.80  
IL-10 added 1 day before SEB  88.30  8.90 2.80  
IL-10 added same time as SEB  83.50  13.00  3.50 
IL-10 added 1 day after SEB  72.10  21.90  6.00  
IL-10 added 2 days after SEB  70.90  22.80  6.30  
IL-10 added 3 days after SEB  70.80  22.90  6.30  
IL-10 added 4 days after SEB  65.80  26.80  7.40  
SEB only  66.15  27.10 6.75 
Treatment Cell Cycle Distribution (%)3-150
G1S G2/M
None >98  <1  <1  
IL-10 added 2 days before SEB  84.50 11.70  3.80  
IL-10 added 1 day before SEB  88.30  8.90 2.80  
IL-10 added same time as SEB  83.50  13.00  3.50 
IL-10 added 1 day after SEB  72.10  21.90  6.00  
IL-10 added 2 days after SEB  70.90  22.80  6.30  
IL-10 added 3 days after SEB  70.80  22.90  6.30  
IL-10 added 4 days after SEB  65.80  26.80  7.40  
SEB only  66.15  27.10 6.75 
F3-150

PBMCs were treated with IL-10 (10 U/mL) at the times indicated and incubated with SEB (100 pg/mL). At 5.5 days after the addition of SEB, cells were collected and analyzed by flow cytometry. Data were gated to analyze CD4+ T cells.

Close Modal

or Create an Account

Close Modal
Close Modal